Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.
Department of Cancer Biology, The Kansas University Medical Center, Kansas City, USA.
Cancer Metastasis Rev. 2023 Mar;42(1):183-196. doi: 10.1007/s10555-023-10090-6. Epub 2023 Jan 31.
Present therapeutic approaches do not effectively target metastatic cancers, often limited by their inability to eliminate already-seeded non-proliferative, growth-arrested, or therapy-resistant tumor cells. Devising effective approaches targeting dormant tumor cells has been a focus of cancer clinicians for decades. However, progress has been limited due to limited understanding of the tumor dormancy process. Studies on tumor dormancy have picked up pace and have resulted in the identification of several regulators. This review focuses on KISS1, a metastasis suppressor gene that suppresses metastasis by keeping tumor cells in a state of dormancy at ectopic sites. The review explores mechanistic insights of KISS1 and discusses its potential application as a therapeutic against metastatic cancers by eliminating quiescent cells or inducing long-term dormancy in tumor cells.
目前的治疗方法并不能有效地针对转移性癌症,这往往是由于它们无法消除已经播散的非增殖性、生长停滞或耐药性肿瘤细胞。几十年来,设计针对休眠肿瘤细胞的有效方法一直是癌症临床医生关注的焦点。然而,由于对肿瘤休眠过程的理解有限,进展一直受到限制。关于肿瘤休眠的研究已经加快了步伐,并确定了几个调节因子。本综述重点介绍 KISS1,这是一种转移抑制基因,通过使肿瘤细胞在异位部位处于休眠状态来抑制转移。该综述探讨了 KISS1 的机制见解,并讨论了其通过消除静止细胞或诱导肿瘤细胞长期休眠来作为治疗转移性癌症的潜在应用。